Medication-related osteonecrosis of the jaw (MRONJ) is a potentially severe adverse event
affecting patients with cancer and patients with osteoporosis who have been treated with …

Objective The main aim is to identify, by means of different imaging modalities, the early
bone changes in patients “at risk” and in stage 0 MRONJ. Materials and methods A search of …

Methods: Fifteen patients with peri-implant bone osteonecrosis were selected out of a group
of 250 patients (6%). Patients were divided into 2 groups according to the temporal …

Osteonecrosis of the jaws (ONJ) is a complication of antiresorptive medications, such as
denosumab or bisphosphonates, prescribed to patients with bone malignancy or …

Dentoalveolar surgery is probably the major risk factor for MRONJ and for other
complications following a tooth extraction, especially in patients affected by systemic …

Objective To assess the outcomes of several rodent animal models for studying tooth
extraction-related medication-related osteonecrosis of the jaw (MRONJ). Design After a …

Objective This study was performed to determine whether the results of prevailing in vivo
and in vitro studies offer a reliable model for investigation of medication-related …

Objective This work aimed to study the role of inflammation in medication-related
osteonecrosis of the jaw (MRONJ) in rats with focus on Wnt signaling. Methods A total of 36 …

Objectives The main challenge in treating bisphosphonate-related osteonecrosis of the jaw
(BRONJ) is the absence of an effective established treatment. We aimed to compare …

The aim of this study was to evaluate the effect of Atorvastatin on Bisphosphonate-induced
osteonecrosis of the jaws of rats. Wistar rats were divided into 4 groups: Saline, Zoledronic …